News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

M Pharmaceuticals USA Announces A Change Of Name To Callitas Therapeutics



8/1/2017 10:44:34 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
CINCINNATI, OH / August 1, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2) ("M Pharma"), announces today that to better align with its expertise in the healthcare field, it is changing the name and branding of its wholly owned subsidiary M Pharmaceutical USA branding to Callitas Therapeutics Inc. The name of the parent company remains as it is for now.

A clinical-stage company developing innovative technologies for weight management and female health and wellness, the new name reflects its broader commitment to drive the innovations needed to shape the future of healthcare. The new corporate website is now - www.callitas.com.

To view the new company logo, please click on the following link:

https://www.accesswire.com/uploads/mpharmimage1new%20logo.jpg

"Our new name, Callitas Therapeutics, reflects our wide-ranging business objective of developing and delivering innovative technologies for weight management and female health and wellness," said Gary Thompson, President and CEO of Callitas Therapeutics and M Pharma. "As a company with its roots in female health and wellness, we are committed to delivering breakthrough products and services that truly improve daily living. Aligning our logo with the beautiful and strong Calla Lily seems most appropriate in light of our mission."

Formed in early 2015, Callitas Therapeutics Inc. is a clinical-stage company developing innovative technologies for obesity, weight management and female health & wellness. In addition to its recent acquisitions of C-103, a reformulation of Orlistat and assets from 40J's LLC, M Pharma is scheduled to launch their FDA cleared fertility product branded as ToConceive sometime in September 2017.

M Pharmaceutical Inc. trades on the Canadian Securities Exchange (CSE) under the ticker symbol "MQ" as well as on the OTCQB as "MPHMF" and FWB (Frankfurt Stock Exchange) as "T3F2."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES